Aim: This article is a report of a study protocol designed to examine patients' and families' knowledge and experiences of peritoneal dialysis-associated peritonitis.
Peritoneal dialysis is a home-based treatment undertaken daily by the patient or their relative. The treatment involves the insertion of a permanent abdominal catheter through which dialysis fluid is filled into the peritoneal cavity, left to dwell and then drained out, removing uraemic toxins and excess water. Patients undertake continuous ambulatory PD (CAPD) during the day or automated PD (APD) overnight using a machine. PD enables the individual to remain at home, promotes self-management and preserves vascular access, which haemodialysis diminishes. Clinical guidelines (due for review in 2017) in the UK recommend PD as the first-line treatment for patients with residual renal function and without "significant associated co-morbidities" (National Institute for Health and Clinical Excellence 2011, 9) . Furthermore, cost-analyses demonstrate that PD is more cost-effective than haemodialysis (Kerr, Bray, Medcalf, O'Donoghue, & Matthews, 2012; Treharne, Liu, Arici, Crowe, & Farooqui, 2014) .
However, peritonitis (infection of the peritoneum) is a significant problem in this patient population, representing the most common complication and principal cause of PD failure (Mactier, 2009) . PDrelated infections, including peritonitis and catheter infections, are caused by: skin or environmental contamination, catheter-related, bacteraemia, bowel and gynaecological flora (Piraino et al., 2011) .
The signs of peritonitis include pyrexia, abdominal pain and cloudy drained effluent and a diagnosis of peritonitis is made when two of the following are present:
• Cloudy PD effluent containing white blood cells >100/mL white blood cells (more than 50% neutrophils);
• Abdominal pain and tenderness and pyrexia; • Positive gram stain or culture identifying micro-organisms in the PD effluent (Li et al., 2010 (Li et al., , 2016 Main, 2014) .
Peritonitis is treated with antibiotics, administered via oral, intravenous or intraperitoneal routes; the prescription varies according to the causative organism (Li et al., 2010) and severity of infection. The patient may require admission to hospital or be able to self-manage the infection at home, with support from PD nurses.
Overall, peritonitis is the cause of death for 4% of patients using PD and a contributing factor for 16% (Li et al., 2016) . Peritonitis can cause peritoneal membrane failure (Li et al., 2016) , which can lead to withdrawal of PD. Other complications include malnutrition, loss of ultrafiltration, fungal peritonitis, intra-abdominal sepsis requiring drainage, adhesions and rarely ileus (Levy, Brown, & Lawrence, 2016) . Peritonitis incidence varies according to PD centre (Bender, Bernardini, & Piraino, 2006; Li et al., 2016; Piraino et al., 2011) and centres are encouraged to monitor the peritonitis incidence, causative organisms and drug susceptibilities (Li et al., 2016) . International guidelines recommend that the overall peritonitis rate in a centre should be no more than 0.5 episodes per year at risk (Li et al., 2016) . Internationally, there is no centralized reporting of peritonitis rates, making it difficult to gain a detailed insight into the numbers of patients affected by peritonitis.
| BACKGROUND

| Knowledge of peritonitis
Patients and their families are taught various aspects of self-management during the PD training process, many of which relate to preventing, monitoring and managing peritonitis (Bernardini, Price, & Figueiredo, 2006) . Therefore, patients and their families are required to learn multiple skills and concepts, which the PD trainer should test the person on before they are left to independently perform PD (Bernardini et al., 2006, 629) . However, two qualitative studies have identified that patients and relatives, may not be familiar with causes of peritonitis nor the signs and symptoms of the infection, leading to a delay in seeking help (Baillie & Lankshear, 2015a,b; Campbell et al., 2016) . A systematic review identified that no studies have examined PD patients' help-seeking behaviours in response to signs of infection (Griva et al., 2014) . While participants learned from their experience (Baillie & Lankshear, 2015a,b) , this is a concerning finding about whether individuals have the knowledge and skills to identify peritonitis and thus safely manage PD at home.
Five studies including the work of researchers in Turkey (Kazancioglu, Ozturk, Ekiz, et al., 2008a; Kazancioglu, Ozturk, Yucel, et al., 2008b; Ozturk, Yucel, Guvenc, Ekiz, & Kazancioglu, 2009 ), Italy (Russo et al., 2006) and Sudan (Sayed, Abu-Aisha, Ahmed, & Elamin, 2013 ) have sought to quantify patients' PD knowledge including peritonitis; one of these studies also included relatives (Russo et al., 2006) . These studies used various author-designed questionnaires to assess knowledge, while Russo et al. (2006) used a questionnaire developed by Baxter Healthcare. The findings of these studies reveal a concerning picture that patients' knowledge of peritonitis is inadequate and this correlates to their likelihood of developing peritonitis. It is evident from this research that there are gaps in patients' and relatives' knowledge related to peritonitis prevention, monitoring and identification.
Why this study is needed
• End-stage renal disease has continued to rise and the use of peritoneal dialysis is increasingly promoted. Peritonitis is a significant problem for patients using peritoneal dialysis, with adverse outcomes.
• Patients undergoing peritoneal dialysis may not be familiar with the signs and symptoms of the infection and better understanding of peritonitis is associated with lower rates of infection.
• No UK studies have examined patients' knowledge of peritoneal dialysis-associated peritonitis and few studies have considered patients' and families' experience of this complication. Russo et al. (2006) identified that participants lacked knowledge in relation to signs of peritonitis, exit-site dressing and maintaining a clean dialysis environment. Participants in Sayed et al.'s (2013) study scored a median of 11.5/35 for knowledge about PD. Overall, 50% of participants were unable to identify signs/symptoms of peritonitis and measures to prevent peritonitis, including handwashing and exitsite care (Sayed et al., 2013) . Kazancioglu, Ozturk, Ekiz, et al. (2008a) identified that patients had a mean knowledge score of 79.8/100; patients scoring highest in the PD exchange procedure (17.4/20), compared with personal hygiene (14.7/20). Kazancioglu, Ozturk, Yucel, et al. (2008b) noted gaps in participants' knowledge, including what peritonitis is and measures to prevent it. Ozturk et al. (2009) identified that knowledge of personal hygiene (including hand washing) was low among study participants. Therefore, it is clear from these studies that there is scope for improvement in patients' knowledge relating to PD and infection prevention and identification.
These studies also demonstrate that patients with increased knowledge about PD and peritonitis are less likely to develop the complication. Sayed et al. (2013) found that patients with higher knowledge scores (in the upper quartile) had lower rates of peritonitis, exit-site infections and hospitalization, while patients who complied with the exchange procedure in Russo et al.'s (2006) study were less likely to develop peritonitis. Kazancioglu, Ozturk, Ekiz, et al. (2008a) identified that the rate of peritonitis was lower in patients with higher knowledge and environment scores. Although work by these researchers was undertaken relatively recently, the studies were conducted at single sites with relatively small numbers of participants, with the exception of Russo et al.'s (2006) study. There is also a dearth of UK studies quantifying patients' and relatives' knowledge of peritonitis. There is thus a need for further research to quantify and explore patients' and families' knowledge of peritonitis.
| Impact of peritonitis
Few studies have sought to explore or quantify the impact of peritonitis on the individual, in terms of quality of life and experience of using PD. This is surprising considering the large body of literature that seeks to quantify quality of life of patients using renal replacement therapies. Interestingly, quality of life studies often exclude patients with peritonitis from their sample, which makes it challenging to understand the impact of the complication on the person's life.
Several quantitative studies have considered the impact of peritonitis on quality of life, although these studies are now dated.
Research by Bakewell, Higgins, and Edmunds (2002) identified that peritonitis was associated with worse quality of life in terms of patient satisfaction. Furthermore, peritonitis was the main reason why patients were hospitalized and hospital admission was independently associated with worse quality of life in terms of physical health, mental health and kidney disease issues (Bakewell et al., 2002) . Peritonitis and catheter tunnel infections were reported to be the primary reasons that patients transferred to haemodialysis (Bakewell et al., 2002) , highlighting the serious consequences of peritonitis for the individual. Juergensen et al. (1996) identified that patients who experienced more than one episode of peritonitis reported significantly worse quality of life, higher anxiety and somatic symptoms.
In their later study, Juergensen et al. (1997) identified that patients with more self-reported symptoms of depression, anxiety and somatic symptoms and lower quality of life, were found to have significantly higher rates of peritonitis. Troidle et al. (2003) identified that patients with depression were found to have significantly greater rates of Gram-positive peritonitis. These findings suggest that there is a relationship between peritonitis and psychosocial outcomes.
A small number of qualitative studies have considered patients' and families' experiences of peritonitis. A recent South African mixed-method study explored the quality of life of patients using peritoneal dialysis and haemodialysis (Tannor, Archer, Kapembwa, van Schalkwyk, & Davids, 2017) . The qualitative phase of the study used focus groups and the findings highlighted that peritonitis was a common complication in the PD group. Fear of contracting peritonitis led some individuals to only undertake CAPD exchanges to the home environment (Tannor et al., 2017 ).
Baillie and Lankshear (2015a) described how maintaining an aseptic procedure during PD exchanges was an important aspect of a complex self-management regimen for patients and their families in the UK. Participants considered peritonitis a threat and worked to prevent and identify the complication. An episode of peritonitis led to increased workload for the patient and their relative, who learned how to manage the complication. Furthermore, peritonitis was associated with guilt, uncertainty and pain (Baillie & Lankshear, 2015a) . Participants demonstrated the stringent procedures to prevent infection, with relatives supporting patients in this process. Ongoing monitoring for signs of infection was an important aspect of self-management, but crucially some participants were not familiar with the signs of infection in reality and were confused about what they should monitor (Baillie & Lankshear, 2015b) . This is particularly concerning if patients and families are to effectively manage PD in the home setting. The diagnosis of peritonitis was found to be upsetting for patients and resulted in antibiotics and hospital admission. Some participants expressed guilt and blame about the cause of the infection (Baillie & Lankshear, 2015b) . available research reveals a relationship between peritonitis, depression, anxiety and quality of life. Furthermore, many of the papers are now dated, with PD and peritonitis management changing since the publication of the earlier studies. Therefore, there is significant scope for further research to consider the impact of this common but serious complication on the lives of patients and their families. This research protocol presents a proposed study that will examine patients' and families' knowledge and experience of PD-associated peritonitis.
3 | THE STUDY
| Aim
The aim of this mixed methods study is to examine patients' and families' knowledge and experiences of PD-associated peritonitis.
Objectives: 
| Study design
To meet the aim and objectives, this study will adopt a sequential explanatory mixed methods design (Creswell, Plano Clark, Gutmann, & Hanson, 2003) , encompassing firstly a survey of patients and their relatives to identify participants' knowledge and experience of peritonitis and secondly semi-structured interviews with a purposive sample of survey respondents. The findings from the interviews will provide further context and enable an in-depth understanding of patients' and families' knowledge and experience of peritonitis (Kroll & Neri, 2009 ).
| Recruitment and sampling
Five purposively selected sites will be included in the study from England and Wales, enabling the recruitment of sufficient numbers of potential participants from different National Health Service (NHS) organizations. These sites have been selected due to their geographically diverse natures and the high number of patients using PD in two of the sites.
Prospective participants will be invited to take part in the study, based on the following criteria:
Phase One:
1. Over 18 years old;
Able to give informed consent;
3. Using PD (either CAPD, APD or both); or used PD within 1 year of study start date, but now using haemodialysis or with a renal transplant;
Research nurse will identify eligible patients according to the inclusion criteria Research nurse will approach the eligible patient and give them a copy of the information pack, including questionnaire participant information sheet and permission to contact form If the potential participant is happy, the nurse will pass on their name and telephone number to the researcher (patient asked to sign permission to contact form)
The researcher will telephone the potential participant and ask if they have any questions about the study. If they are happy to proceed, a time and date will be agreed for the questionnaire The researcher will read each point on the consent form to the potential participant, audiorecording the conversation. If the particiapnt agrees to each point, the researcher will initial the relevant box on the consent form. The researcher will then sign the consent form The researcher will adminster the questionnaire via the telephone, documenting the participant's responses on a Bristol Online Survey
The researcher will post a copy of the consent form to the participant Patients who are using peritoneal dialysis, or are using haemodialysis or have a functioning transplant who have previously used PD within 1 year of the study start date, will be invited to participate. This is to ensure that a range of perspectives is gathered, including people who may have had to change therapies due to PD-associated peritonitis.
Phase One: A research nurse in each site will identify potential participants who fit the inclusion criteria and give them a study information pack. Potential participants are asked to complete a permission to contact form and return it to the research nurse, who will give these forms to the researcher. The researcher will then telephone the participant and discuss any questions they may have. The researcher will take consent over the telephone, which will be audio recorded, prior to the delivery of the questionnaire. This process is outlined in Figure 1 and has used successfully in previous research undertaken over the telephone (Irvine, 2010) . Patient participants will be asked to identify if a relative supports them to use PD. If so, they will be invited to give their relative a copy of the relative questionnaire participant information sheet.
Response rates for surveys vary considerably between participant groups and method of administration. The previously published PD knowledge surveys included between 15 and 353 participants (Kazancioglu, Ozturk, Ekiz, et al., 2008a; Kazancioglu, Ozturk, Yucel, et al., 2008b; Ozturk et al., 2009) , but the response rates are not reported.
A power calculation is not appropriate for this study as a hypothesis is not being tested. The latest UK Renal Registry report identified that 354 patients use PD at the five study sites (MacNeill et al., 2016) , the number of patients using another renal replacement therapy who previously used PD within 1 year of the study start date is unknown. It is also unknown how many patients will agree to include a relative in the study. Therefore, the potential sample size is difficult to calculate and this is recognized as a limitation of the study.
Phase Two: At the end of the questionnaire, Phase One participants will be asked whether they would be willing to take part in an interview with the researcher and, if so, to provide their name, address, age, current renal replacement therapy, type of peritoneal dialysis they use or previously used (CAPD/APD) and whether they have experienced peritonitis. A maximum variation purposive sample (Patton, 2002) will be selected using this information from those who have expressed an interest to participate, allowing for variety in the sample. Patients and relatives will be included to promote insight into the experiences of a range of participants. Participants will be recruited and data collected until data saturation has been reached, whereby no new themes are being revealed (Guest, Bunce, & Johnson, 2006) . It is anticipated that up to 30 patients/relatives will be included; Baillie and Lankshear (2015b) To gain an understanding of patients' and families' knowledge, understanding and experience of peritonitis, a telephone questionnaire will be administered. This structured approach will enable the generation of comparable data (de Vaus, 2002) , providing insight into the perspectives of a sample of participants using peritoneal dialysis.
Due to the demands of managing PD at home, the questionnaire is structured and includes simple yes/no and "select all that apply" questions and the length is limited to reduce burden to participants. Each section is described below.
Part one: Knowledge of peritonitis
The first part of the questionnaire asks respondents nine questions about their knowledge of peritonitis (eight questions for patients using CAPD). These questions were developed from previously used questionnaires (Kazancioglu, Ozturk, Ekiz, et al., 2008a; Ozturk et al., 2009; Russo et al., 2006; Sayed et al., 2013) , clinical guidelines (Li et al., 2016) , renal textbooks (Levy et al., 2016; Main, 2014) , patient literature (Oakley, 2016) and dialysis company literature (Baxter 2009 ). Overall, the correct answers add up to a score of 31 (30 for CAPD patients).
Part two: Experience of peritonitis
Part two of the questionnaire encompasses up to eight questions relating to patients' experiences of peritonitis. While experience of peritonitis will primarily be investigated during the interviews with participants in phase two, where the topic can be explored in-depth, BAILLIE ET AL.
| 205 the questionnaire questions enable the generation of comparable data providing an overview. There are no previous questionnaires that have sought to examine patients'/relatives' experiences of peritonitis and the questions were thus generated through clinical guidelines Figueiredo et al., 2016; Li et al., 2016) , questions from part one of the questionnaire and earlier qualitative research on experience of peritonitis (Baillie & Lankshear, 2015b ).
There is not a correct score total for this section. The questionnaire will be piloted with the first ten participants at the first study site. This will involve asking participants whether they think the questions make sense and are clear and whether any questions should be added (Sapsford, 2007) . If only minor changes are required, these responses will be included in the main study data collection.
Part three: Demographic questions
| Phase two: Semi-structured interviews
Following on from Phase One, semi-structured interviews will be conducted. Participants will be given the option whether to take part in an interview over the telephone/Skype or face-to-face; these approaches have been successfully used with this population in previous studies (Baillie & Lankshear, 2015b; Campbell et al., 2016) . For telephone or Skype interviews, consent will be taken as described in Phase One. Consent for interviews in person will involve both the participant and researcher signing the consent form together in person.
Participants will be interviewed using a semi-structured approach about their knowledge, understanding and experience of peritonitis, enabling the generation of rich data (Heyl, 2007) . In particular, interviews will focus on experience of peritonitis, which cannot be fully explored in a structured survey. An interview schedule has been developed with reference to the literature, but will be informed by Phase One findings. For example, if an area of concern has been identified in the questionnaire data, this will be explored in the interviews, such as training following an episode of peritonitis.
The interviews will be conversational (Spradley, 1979) , ensuring that participants talk about issues important to them.
Interviews will be digitally audio recorded and will last around 45 minutes. Audio recordings will be transcribed verbatim by a professional transcriber. Patients and relatives may be interviewed together or separately, according to their preference, but families often expect to be interviewed together (Baillie & Lankshear, 2015a ), due to their mutual experience of a long-term condition. Phase Two: Data analysis will commence during data generation, ensuring an iterative approach (Hammersley & Atkinson, 1995) . The data will be managed using NVivo 11 and the data will be analysed thematically, adopting Wolcott's (1994) approach: Description, Analysis and Interpretation. This approach involves identifying a coding framework and coding the data, considering the meaning of the data and identifying themes and finally interpreting these themes and considering them in relation to the wider literature.
Interpretation: The data from the two phases will then be synthesized. This is a crucial stage of a mixed methods study (Kroll & Neri, 2009) , a requirement of which is the integration of the data from the different methods. Creswell et al. (2003) recommend that data from sequential explanatory mixed methods studies are integrated at the interpretation phase of the study. Therefore, the qualitative and quantitative data considering participants' knowledge of peritonitis will be interpreted together, as will the data considering participants' experience of peritonitis.
| Ethical Considerations
This study will be undertaken with reference to the Research 
| Rigour
To promote integrity and quality in this mixed methods study, appropriate validation strategies will be applied for each phase of the study (Giddings & Grant, 2009 ).
Phase One: To ensure content validity the questionnaire items were generated with input from experts in the field, including a renal patient and reviewing relevant literature (Rattray & Jones, 2005) . Following ethical approval, the questionnaire will be piloted as described above in one site to identify questions that lack clarity (Rattray & Jones, 2005) . Questions in part three of the questionnaire will enable the sample to be described and compared with UK Renal Registry data to see how representative the sample is of the PD population. This will be particularly useful to increase validity as the study sample cannot be randomly selected (Sapsford, 2007) .
Phase Two: To ensure the trustworthiness of the research credibility, transferability, dependability and confirmability will be considered (Guba & Lincoln, 1989 ). Credibility will be promoted in this study by interviewing both patients and relatives (Denscombe, 2010) . Furthermore, throughout data collection and analysis a research journal will be completed documenting decisions and choices (Coffey & Atkinson, 1996; Finlay, 2003; Koch, 1994) , which is an important aspect of researcher reflexivity (Koch, 1994) . Fieldnotes will also be written following each interview to contextualize the interactions (Coffey & Atkinson, 1996) . To increase the transferability of the study findings, each study site will be described and information about individual participants will be documented at the start of each semi-structured interview (Guba & Lincoln, 1989) . The dependability and confirmability of the research will be promoted by completing an audit trail (Koch, 1994) .
| DISCUSSION
This protocol has outlined a proposed mixed methods study that will use a questionnaire and interviews, with patients and relatives, at five sites in England and Wales. It is anticipated that the findings of this study will be used to develop an intervention to meet the information and support needs of this population, which will then be tested in a future study. Therefore, this study fits in the "develop- 
| Limitations
There are acknowledged limitations to this study. The sample in Phase One is not a random sample as is preferable for questionnaire studies (Sapsford, 2007) . However, this is not feasible due to the unknown numbers of potential participants. Therefore, the approach chosen will ensure that all patients and relatives meeting the inclusion criteria at the five study sites will have the opportunity to participate in the study. The five study sites are geographically diverse and located in Wales and England, to promote diversity in the sample.
The questionnaire used for this study is author-designed and not a validated measure, which is recognized as a limitation. The previously published questionnaires on PD knowledge (Kazancioglu, BAILLIE ET AL.
| 207 Ozturk, Ekiz, et al., 2008a; Ozturk et al., 2009; Russo et al., 2006; Sayed et al., 2013) are also author-designed and did not focus specifically on peritonitis knowledge. Therefore, a new peritonitis knowledge questionnaire was developed following extensive literature reviewing and with input from a variety of researchers, healthcare professionals and a patient. This questionnaire will also be piloted as described above.
Finally, it would be preferable to interview all participants in phase two in person. However, this is not feasible due to the wide geographical spread of participants. Interviewing participants from different geographical locations provides insight into the perspectives of different groups of people and gives them the opportunity to participate in research. Non-face-to-face interviews have been undertaken successfully with this patient population in previous research (Campbell et al., 2016) .
| CONCLUSION
This protocol has outlined the rationale and design of a mixed methods study to examine the knowledge and experience of PD-associated peritonitis. There are relatively few studies that have considered this topic and the proposed study will therefore provide insight into both patients' and families' peritonitis knowledge and experience. This is necessary to ensure that patients and families are able to prevent, monitor and identify peritonitis and are supported if an episode of infection occurs. With the increasing number of patients with end-stage renal disease, this is vital to promote the well-being and outcomes of patients using PD.
